- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04593160
Efficacy of Preoperative Diclofenac Potassium- Acetaminophen Combination on Anesthetic Success in Patients With Symptomatic Irreversible Pulpitis: a Randomized Controlled Trial
October 28, 2020 updated by: Sovana Tarek, Cairo University
The purpose of this study is to assess the effect of preoperative a single-dose of 50 mg diclofenac potassium- 1000mg acetaminophen combination compared to diclofenac potassium alone or placebo on local anesthetic success and postoperative pain in patients with symptomatic irreversible pulpitis.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Patients with moderate-to-severe preoperative pain are selected.
Patients receive either a single-dose of diclofenac potassium (50mg)- acetaminophen (1000mg) combination, diclofenac potassium (50mg) alone or a placebo tablet as a control.
All patients will receive the assigned premedication one hour before single-visit root canal treatment.
Anesthetic success of inferior alveolar nerve block will be assessed during access and instrumentation.
Postoperative endodontic pain is measured at the following time points: 6,12,24,48,72h and 7 days after treatment.
Study Type
Interventional
Enrollment (Anticipated)
72
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sovana T. Abd El-Monem
- Phone Number: +201005173697
- Email: sovana.tarek241@gmail.com
Study Contact Backup
- Name: Suzan Amin
- Email: suzan.wanis@dentistry.cu.edu.eg
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with symptomatic irreversible pulpitis with/without mechanical allodynia
- Patients with moderato to severe spontaneous pain
- Mandibular molars
- Patients with the ability to understand and use the pain scale
- Patients accepting enrollment in the study
Exclusion Criteria:
- Patients allergic to any medication or material to be used in the study
- Pregnant and lactating females
- Patients taking medications affecting pain perception in the last 12 hours
- Patients having more than one symptomatic molar in the same quadrant
- Patients with contributory medical history (ASA > II)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Diclofenac potassium- acetaminophen combination
Preoperative single dose of diclofenac potassium(50mg)- acetaminophen(1000mg) combination
|
Preoperative single dose of diclofenac potassium(50mg)- acetaminophen(1000mg) combination
|
EXPERIMENTAL: Diclofenac potassium
Preoperative single dose of diclofenac potassium(50mg)
|
Preoperative single dose of diclofenac potassium(50mg)
|
PLACEBO_COMPARATOR: Placebo
Preoperative single dose of placebo
|
Preoperative single dose of placebo
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anesthetic success of inferior alveolar nerve block
Time Frame: During the treatment
|
Will be recorded by 11 point NRS consisting of numbers from 0 through 10. 0: reading represents "no pain" 1-3 : readings represent "mild pain" 4-6 : readings represent "moderate pain" 7-10 : readings represent "severe pain" 0: reading represents "no pain" 1-3 : readings represent "mild pain" 4-6 : readings represent "moderate pain" 7-10 : readings represent "severe pain".
Success will be defined as no to mild pain.
|
During the treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postoperative pain at 6 hours
Time Frame: 6 hours
|
Will be recorded by 11 point NRS consisting of numbers from 0 through 10. 0: reading represents "no pain" 1-3 : readings represent "mild pain" 4-6 : readings represent "moderate pain" 7-10 : readings represent "severe pain" 0: reading represents "no pain" 1-3 : readings represent "mild pain" 4-6 : readings represent "moderate pain" 7-10 : readings represent "severe pain"
|
6 hours
|
Postoperative pain at 12 hours
Time Frame: 12 hours
|
Will be recorded by 11 point NRS consisting of numbers from 0 through 10. 0: reading represents "no pain" 1-3 : readings represent "mild pain" 4-6 : readings represent "moderate pain" 7-10 : readings represent "severe pain" 0: reading represents "no pain" 1-3 : readings represent "mild pain" 4-6 : readings represent "moderate pain" 7-10 : readings represent "severe pain"
|
12 hours
|
Postoperative pain at 24 hours
Time Frame: 24 hours
|
represents "no pain" 1-3 : readings represent "mild pain" 4-6 : readings represent "moderate pain" 7-10 : readings represent "severe pain" 0: reading represents "no pain" 1-3 : readings represent "mild pain" 4-6 : readings represent "moderate pain" 7-10 : readings represent "severe pain"
|
24 hours
|
Postoperative pain at 48 hours
Time Frame: 48 hours
|
represents "no pain" 1-3 : readings represent "mild pain" 4-6 : readings represent "moderate pain" 7-10 : readings represent "severe pain" 0: reading represents "no pain" 1-3 : readings represent "mild pain" 4-6 : readings represent "moderate pain" 7-10 : readings represent "severe pain"
|
48 hours
|
Postoperative pain at 72 hours
Time Frame: 72 hours
|
represents "no pain" 1-3 : readings represent "mild pain" 4-6 : readings represent "moderate pain" 7-10 : readings represent "severe pain" 0: reading represents "no pain" 1-3 : readings represent "mild pain" 4-6 : readings represent "moderate pain" 7-10 : readings represent "severe pain"
|
72 hours
|
Postoperative pain at 7 days
Time Frame: 7 days
|
represents "no pain" 1-3 : readings represent "mild pain" 4-6 : readings represent "moderate pain" 7-10 : readings represent "severe pain" 0: reading represents "no pain" 1-3 : readings represent "mild pain" 4-6 : readings represent "moderate pain" 7-10 : readings represent "severe pain"
|
7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Nagendrababu V, Pulikkotil SJ, Veettil SK, Teerawattanapong N, Setzer FC. Effect of Nonsteroidal Anti-inflammatory Drug as an Oral Premedication on the Anesthetic Success of Inferior Alveolar Nerve Block in Treatment of Irreversible Pulpitis: A Systematic Review with Meta-analysis and Trial Sequential Analysis. J Endod. 2018 Jun;44(6):914-922.e2. doi: 10.1016/j.joen.2018.02.017. Epub 2018 Apr 27.
- Ianiro SR, Jeansonne BG, McNeal SF, Eleazer PD. The effect of preoperative acetaminophen or a combination of acetaminophen and Ibuprofen on the success of inferior alveolar nerve block for teeth with irreversible pulpitis. J Endod. 2007 Jan;33(1):11-4. doi: 10.1016/j.joen.2006.09.005.
- Al-Rawhani AH, Gawdat SI, Wanees Amin SA. Effect of Diclofenac Potassium Premedication on Postendodontic Pain in Mandibular Molars with Symptomatic Irreversible Pulpitis: A Randomized Placebo-Controlled Double-Blind Trial. J Endod. 2020 Aug;46(8):1023-1031. doi: 10.1016/j.joen.2020.05.008. Epub 2020 May 26.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
January 1, 2021
Primary Completion (ANTICIPATED)
December 1, 2021
Study Completion (ANTICIPATED)
March 1, 2022
Study Registration Dates
First Submitted
October 13, 2020
First Submitted That Met QC Criteria
October 13, 2020
First Posted (ACTUAL)
October 19, 2020
Study Record Updates
Last Update Posted (ACTUAL)
October 30, 2020
Last Update Submitted That Met QC Criteria
October 28, 2020
Last Verified
October 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Stomatognathic Diseases
- Tooth Diseases
- Dental Pulp Diseases
- Pulpitis
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Peripheral Nervous System Agents
- Enzyme Inhibitors
- Analgesics
- Sensory System Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antirheumatic Agents
- Cyclooxygenase Inhibitors
- Antipyretics
- Acetaminophen
- Diclofenac
Other Study ID Numbers
- CU-ENDO-6-10-2020.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Symptomatic Irreversible Pulpitis
-
Cairo UniversityNot yet recruitingSymptomatic Irreversible Pulpitis
-
University of California, San FranciscoWithdrawnSymptomatic Irreversible Pulpitis
-
Indiana UniversityRecruitingSymptomatic Irreversible PulpitisUnited States
-
Cairo UniversityNot yet recruitingSymptomatic Irreversible Pulpitis
-
Indiana UniversityRecruitingSymptomatic Irreversible PulpitisUnited States
-
Farjad ZafarCompletedSymptomatic Irreversible PulpitisPakistan
-
Rubén Domínguez PérezCompletedSymptomatic Irreversible PulpitisMexico
-
Cairo UniversityUnknownSymptomatic Irreversible PulpitisEgypt
-
Isfahan University of Medical SciencesCompletedSymptomatic Irreversible PulpitisIran, Islamic Republic of
-
Daniel Chavarría BolañosCompletedSymptomatic Irreversible PulpitisMexico
Clinical Trials on Diclofenac potassium- acetaminophen combination
-
Novartis PharmaceuticalsTerminated
-
Aswan University HospitalCompletedInfertility, FemaleEgypt
-
Novartis PharmaceuticalsCompleted
-
Humanis Saglık Anonim SirketiCompletedBioequivalence Study to Compare Diclofenac Potassium Coated Tablet Versus Cataflam® 50 Coated TabletAnalgesic | Non-steroidal Anti-inflammatory (NSAID) | AntipyreticJordan
-
The University of Texas Health Science Center,...CompletedPain Control After Functional Endoscopic Sinus Surgery and SeptoplastyUnited States
-
University of ZimbabweUZ-CHS-PERFECTSuspendedImpacted Third Molar Tooth | PAINZimbabwe
-
Al-Azhar UniversityCompletedOral Infection | Oral Ulcer | Oral Mucositis | ORASEgypt
-
Javelin PharmaceuticalsCompleted
-
DepomedCompleted
-
Clinical Research Centre, MalaysiaCompletedPerineal Tear | Perineal Laceration (Obstetric)